Ramipril Capsule
Product Images NDC 68382-147

7 FDA label images from Zydus Pharmaceuticals Usa Inc. · Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 7 technical images submitted to the FDA as part of the official labeling for Ramipril (NDC 68382-147). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Zydus Pharmaceuticals Usa Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Structured Product Formula For Ramipril (F36e6ac7 0cfb 4450 A2f2 84064a9c7d3a 01)

Structured Product Formula For Ramipril (F36e6ac7 0cfb 4450 A2f2 84064a9c7d3a 01)
Chemical structure diagram of Ramipril showing its molecular components and bonds in a two-dimensional format.*
FDA Label Image

Figure 1 (F36e6ac7 0cfb 4450 A2f2 84064a9c7d3a 02)

Figure 1 (F36e6ac7 0cfb 4450 A2f2 84064a9c7d3a 02)
Kaplan-Meier curve depicting the composite outcome of myocardial infarction, stroke, or death from cardiovascular causes in patients treated with Ramipril versus placebo. The y-axis shows the proportion of patients, while the x-axis represents days of follow-up. The graph illustrates lower event proportions in the Ramipril group compared to placebo over time, with a P-value of 0.0001 indicating statistical significance.*
FDA Label Image

Figure 2 (F36e6ac7 0cfb 4450 A2f2 84064a9c7d3a 03)

Figure 2 (F36e6ac7 0cfb 4450 A2f2 84064a9c7d3a 03)
A forest plot chart titled 'The Beneficial Effect of Treatment with Ramipril on the Composite Outcome of Myocardial Infarction, Stroke, or Death from Cardiovascular Causes Overall and in Various Subgroups.' It displays relative risk in the Ramipril group versus placebo across multiple patient subgroups, including cardiovascular disease status, diabetes, age, sex, hypertension, coronary artery disease history, prior myocardial infarction, cerebrovascular disease, peripheral vascular disease, and microalbuminuria. The x-axis represents relative risk with confidence intervals for each subgroup point estimate.*
FDA Label Image

Ramipril Capsules, 1.25 mg (F36e6ac7 0cfb 4450 A2f2 84064a9c7d3a 04)

Ramipril Capsules, 1.25 mg (F36e6ac7 0cfb 4450 A2f2 84064a9c7d3a 04)
Label for Ramipril Capsules USP 1.25 mg by Zydus Pharmaceuticals USA Inc., containing 30 oral capsules. The label shows the product name, strength 1.25 mg, packaging quantity, barcode, and storage and usage warnings. Manufactured by Zydus Lifesciences Ltd., India, and distributed by Zydus Pharmaceuticals USA Inc.*
FDA Label Image

Ramipril Capsules, 2.5 mg (F36e6ac7 0cfb 4450 A2f2 84064a9c7d3a 05)

Ramipril Capsules, 2.5 mg (F36e6ac7 0cfb 4450 A2f2 84064a9c7d3a 05)
Label for Ramipril Capsules USP 2.5 mg, oral capsules in a bottle count of 100, labeled by Zydus Pharmaceuticals USA Inc. The label includes the NDC 68382-145-01, dosage strength prominently displayed, storage and pharmacist dispensing instructions, and manufacturer information noting Zydus Lifesciences Ltd., Ahmedabad, India.*
FDA Label Image

Ramipril Capsules, 5 mg (F36e6ac7 0cfb 4450 A2f2 84064a9c7d3a 06)

Ramipril Capsules, 5 mg (F36e6ac7 0cfb 4450 A2f2 84064a9c7d3a 06)
Label for Ramipril Capsules USP 5 mg oral capsules by Zydus Pharmaceuticals USA Inc. The label indicates a bottle containing 100 capsules with a prescription-only designation. The label includes storage instructions, pharmacist dispensing guidance, and manufacturer information stating Zydus Lifesciences Ltd., Ahmedabad, India, with distribution by Zydus Pharmaceuticals USA Inc., Pennington, NJ.*
FDA Label Image

Ramipril Capsules, 10 mg (F36e6ac7 0cfb 4450 A2f2 84064a9c7d3a 07)

Ramipril Capsules, 10 mg (F36e6ac7 0cfb 4450 A2f2 84064a9c7d3a 07)
Label for Ramipril Capsules USP 10 mg, oral dosage form. The label shows that the product contains 100 capsules and is prescription-only (Rx only). Manufacturer is Zydus Lifesciences Ltd., Ahmedabad, India, and it is distributed by Zydus Pharmaceuticals USA Inc., Pennington, NJ. Storage instructions and pharmacist dispensing guidelines are also included on the label.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.